Search Results for 'question hiv'

question hiv published presentations and documents on DocSlides.

Pre-Exposure Prophylaxis ( PrEP )  for HIV Infection Jeffrey D. Klausner, MD, MPH
Pre-Exposure Prophylaxis ( PrEP ) for HIV Infection Jeffrey D. Klausner, MD, MPH
by kittie-lecroy
Pre-Exposure Prophylaxis ( PrEP ) for HIV Infect...
Election Advocacy and the HIV/AIDS Community
Election Advocacy and the HIV/AIDS Community
by mitsue-stanley
2012 Election Advocacy. www.HIVHealthReform.org/H...
Election Advocacy and the HIV/AIDS Community
Election Advocacy and the HIV/AIDS Community
by ellena-manuel
2012 Election Advocacy. www.HIVHealthReform.org/H...
Elimination of Hepatitis C in Individuals With HIV Infection
Elimination of Hepatitis C in Individuals With HIV Infection
by hugo
David L. Thomas, MD, MPH. Professor of Medicine. T...
Be Proud! Be Responsible!
Be Proud! Be Responsible!
by GratefulHeart
Module 2: Building Knowledge About HIV. Activity A...
Cases From the Clinic( ians
Cases From the Clinic( ians
by ImNotABaby
):. Antiretroviral Therapy Cases . and . Panel Dis...
Question An Exception  -  Not Baboons
Question An Exception - Not Baboons
by trish-goza
Only 2 of 279 baboons in Tanzania and Ethiopia we...
Question An Exception  -  Not Baboons
Question An Exception - Not Baboons
by lindy-dunigan
Only 2 of 279 baboons in Tanzania and Ethiopia we...
New Developments in Opportunistic Infections: Interactive Case-Based Panel Discussion
New Developments in Opportunistic Infections: Interactive Case-Based Panel Discussion
by marina-yarberry
Stephen P. Raffanti, MD, MPH. Professor of Medici...
Michael S.  Saag , MD Professor of Medicine
Michael S. Saag , MD Professor of Medicine
by roxanne
Associate Dean for Global Health. University of Al...
Situation Analysis for the Introduction of the PrEP Ring
Situation Analysis for the Introduction of the PrEP Ring
by jovita
Overview and Instructions. PLAN. 4 . RING . TOOLK...
Drug Interactions and Polypharmacy
Drug Interactions and Polypharmacy
by trinity
in . the Management of . HIV: . A Case-Based Discu...
Clinical and immunological outcomes of
Clinical and immunological outcomes of
by jacey
children with antenatal HIV and CMV exposure. Ceri...
Sex Jeopardy!
Sex Jeopardy!
by stefany-barnette
By team YEAH . Contraception. Love Bugs. Culture....
Community Scorecard Group Facilitator and Key Informant Interviewer Training
Community Scorecard Group Facilitator and Key Informant Interviewer Training
by murphy
July 2021. Agenda. MORNING. Welcome and introducti...
Dapivirine  Ring Introduction Framework and Key Insights
Dapivirine Ring Introduction Framework and Key Insights
by valerie
PLAN. 4 . RING . TOOLKIT. PROMISE. Preparing for ...
Session 6:  Methamphetamine and Cocaine (2)
Session 6: Methamphetamine and Cocaine (2)
by DaintyLittlePrincess
Psycho-Education for Patients and Family Members. ...
Toxoplasmosis Learning Objectives
Toxoplasmosis Learning Objectives
by bikershomemaker
Introduction. Life Cycle. Epidemiology. Pathologen...
Self-Study Modules  on Tuberculosis, 1-5
Self-Study Modules on Tuberculosis, 1-5
by test
Centers for Disease Control and Prevention. Divis...
Improving
Improving
by alexa-scheidler
Physician-Patient Adherence Communication. Ira W...
Syringe Access Programs & Law Enforcement:
Syringe Access Programs & Law Enforcement:
by briana-ranney
Building Alliances. New York State. Current April...
The 12-Dose INH-Rifapentine Once-Weekly DOT Regimen:
The 12-Dose INH-Rifapentine Once-Weekly DOT Regimen:
by briana-ranney
What Next?. CTCA Conference 2012. John Jereb, FSE...